Istituto Tumori Giovanni Paolo II IRCSS; Ospedale Oncologico Bari

Bari, Apulia 70126

0 studies enrolling now · 2 studies all time

What they study most

Malignant Melanoma, Melanoma

Studies at this site

• A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma — Completed
• A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma — Completed